Exopharm Limited announced the appointment of Dr. Jennifer (Jenn) King to the Exopharm Board, effective 1 September 2021. Dr. King joins the Company's Board as an independent Non-executive Director, and will continue in her role as a member of the Company's Advisory Panel under her existing terms of appointment to the Panel. More recently Jenn served as the Senior Vice President, Business Development of Intellia Therapeutics Inc.